Early Crohn disease: a proposed definition for use in disease-modification trials

被引：106
|
作者：
Peyrin-Biroulet, Laurent [1 ]
Loftus, Edward V., Jr. [1 ]
Colombel, Jean-Frederic [2 ]
Sandborn, William J. [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, Inflammatory Bowel Dis Clin, Rochester, MN 55905 USA
[2] CHU Lille, Hop Claude Huriez, F-59037 Lille, France
来源：
GUT | 2010年 / 59卷 / 02期
关键词：
EARLY RHEUMATOID-ARTHRITIS; INFLAMMATORY-BOWEL-DISEASE; POPULATION-BASED COHORT; C-REACTIVE PROTEIN; NATURAL-HISTORY; COMPUTED-TOMOGRAPHY; CYTOKINE PRODUCTION; RADIATION-EXPOSURE; CLINICAL-TRIALS; OLMSTED COUNTY;
D O I：
10.1136/gut.2009.187120
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：141 / 147
页数：7
相关论文
共 50 条
  • [31] Monoamine oxidase-B (MAO-B) inhibitors: Implications for disease-modification in Parkinson's disease
    Teo K.C.
    Ho S.-L.
    Translational Neurodegeneration, 2 (1)
  • [32] Use of the Crohn's disease activity index in clinical trials of biological agents
    Freeman, Hugh James
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (26) : 4127 - 4130
  • [33] Use of the Crohn's disease activity index in clinical trials of biological agents
    Hugh James Freeman
    World Journal of Gastroenterology, 2008, (26) : 4127 - 4130
  • [34] WHAT IS THE BEST DEFINITION OF MUCOSAL HEALING IN CROHN DISEASE?
    Yzet, Clara
    Loreau, Julien
    LeMouel, Jean-Philippe
    Brazier, Franck
    Nguyen-Khan, Eric
    Dupas, Jean-Louis
    Fumery, Mathurin
    GASTROENTEROLOGY, 2017, 152 (05) : S210 - S210
  • [35] Effect of early immunomodulator use in moderate to severe pediatric Crohn disease
    Punati, Jaya
    Markowitz, James
    Lerer, Trudy
    Hyams, Jeffrey
    Kugathasan, Subra
    Griffiths, Anne
    Otley, Anthony
    Rosh, Joel
    Pfefferkorn, Marian
    Mack, David
    Evans, Jonathon
    Bousvoros, Athos
    Moyer, M. Susan
    Wyllie, Robert
    Oliva-Hemker, Maria
    Mezoff, Adam
    LeLeiko, Neal
    Keljo, David
    Crandall, Wallace
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (07) : 949 - 954
  • [36] Predictors of immunomodulator use as early therapy in pediatric Crohn's disease
    Jacobstein, DA
    Mamula, P
    Markowitz, JE
    Leonard, M
    Baldassano, RN
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (02) : 145 - 148
  • [37] Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders
    Vissers, Maurits F. J. M.
    Heuberger, Jules A. A. C.
    Groeneveld, Geert Jan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 33
  • [38] fMRI: use in early Alzheimer's disease and in clinical trials
    Pihlajamiki, Maija
    Sperling, Reisa A.
    FUTURE NEUROLOGY, 2008, 3 (04) : 409 - 421
  • [39] Timely Use of Biologics in Early Crohn’s Disease: The Return of “Hit Hard and Early”?
    Catherine Le Berre
    Silvio Danese
    Laurent Peyrin-Biroulet
    Digestive Diseases and Sciences, 2019, 64 : 3035 - 3037
  • [40] Timely Use of Biologics in Early Crohn's Disease: The Return of "Hit Hard and Early"?
    Le Berre, Catherine
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (11) : 3035 - 3037
12345